SCHEMBL17526883

SCHEMBL17526883

CCCC[C@@H](CCCO)OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 3/20 0.42
TSHR P16473 2/20 0.42
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PRKCA P17252 2/20 0.38
PRKCD Q05655 2/20 0.38
PRKD3 O94806 1/20 0.38
PRKCG P05129 1/20 0.38
PRKCB P05771 1/20 0.38
PRKCH P24723 1/20 0.38
PRKCI P41743 1/20 0.38
PRKCE Q02156 1/20 0.38
PRKCQ Q04759 1/20 0.38
PRKCZ Q05513 1/20 0.38
PRKD1 Q15139 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17526575 1.00 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL11669709 1.00 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL17526803 0.93 SMN1; SMN2 (0.48) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL17526910 0.93 SMN1; SMN2 (0.48) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL17526873 0.91 LMNA (0.50) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL17527025 0.91 LMNA (0.50) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL1657472 0.91 SMN1; SMN2 (0.43) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL6523251 0.90 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL1556424 0.88 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL807201 0.87 DNM1 (0.41) ALDH1A1SMN1; SMN2LMNATSHRPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2016-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 ALDH1A1 2376/4885SMN1; SMN2 649/4885LMNA 3497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.